Update on monitoring and adverse effects of approved second-generation disease-modifying therapies in relapsing forms of multiple sclerosis. [electronic resource]
Producer: 20180109Description: 278-85 p. digitalISSN:- 1473-6551
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.